Mounjaro Price 2026: Cost Without Insurance and Where to Get It

Mounjaro (tirzepatide) pen
Brand-name tirzepatide for type 2 diabetes

Mounjaro

Mounjaro is approved for type 2 diabetes, not weight loss. Without insurance, it costs $499 a month at every dose on LillyDirect, Lilly’s self-pay pharmacy. With a commercial plan that covers it, Lilly’s savings card can bring a fill down to $25, and Medicare Part D plans can cover it for diabetes.
Once-weekly injection FDA-approved For type 2 diabetes Not approved for weight loss
LillyDirect self-pay $499/mo
Commercial plan that covers it From $25
Medicare Part D (type 2 diabetes) Plan copay
Commercial plan that doesn’t cover it From $499/mo
Prices checked Sep 25, 2026 on LillyDirect and Lilly’s savings page

What Mounjaro is Approved for:

  • Adults and children 10 and older with type 2 diabetes, along with diet and exercise, to improve blood sugar control
  • Lowering the risk of heart attack, stroke and heart-related death in adults with type 2 diabetes who are at high risk for these events
Mounjaro is not approved for weight loss. Zepbound has the same active ingredient and is approved for weight management and sleep apnea. Source: Mounjaro label on DailyMed (August 2026).
Last Updated:

How Much Does Mounjaro Cost? Every Way to Pay

What you pay for Mounjaro depends mostly on how you pay: insurance or Medicare Part D for type 2 diabetes, a commercial plan with Lilly’s savings card, or cash at Lilly’s self-pay price. The table lists each route with the price we found and the date we checked it.
Way to payWhat you payGood to knowChecked
Way to pay
LillyDirect self-pay
Pen
What you pay
$499 per month
Good to know
The same price at every dose, 2.5 to 15 mg. Additional taxes and fees may apply.
Checked
Sep 25, 2026
lilly.com
Way to pay
Commercial plan that covers Mounjaro
Pen
What you pay
From $25 per fill
Good to know
Lilly’s savings card: $25 for a 1-, 2- or 3-month fill, with savings up to $450 per 3-month fill and $1,950 a year. The card ends December 31, 2026.
Checked
Sep 25, 2026
mounjaro.lilly.com
Way to pay
Commercial plan that doesn't cover Mounjaro
Pen
What you pay
From $499 per month
Good to know
With Lilly’s savings card, as low as $499 for a 1-month fill, with savings up to $8,411 a year.
Checked
Sep 25, 2026
mounjaro.lilly.com
Way to pay
Medicare Part D (type 2 diabetes)
Pen
What you pay
Plan copay
Good to know
Part D plans can cover Mounjaro for type 2 diabetes at the plan’s normal copays. The $50 GLP-1 Bridge doesn’t cover Mounjaro.
Checked
Sep 26, 2026
medicare.gov
Way to pay
Telehealth resellers
Pen
What you pay
$1,349–$1,399 per month
Good to know
Some telehealth sites sell the pen themselves: Pallas Health at $1,349 a month, Wellorithm (3 months paid upfront) and Eden at $1,399. That’s nearly three times Lilly’s $499 self-pay price.
Checked
Way to pay
Zepbound, the same drug for weight loss
VialKwikPen
What you pay
$299–$449 per month
Good to know
Tirzepatide approved for weight management, at Lilly’s self-pay price on LillyDirect. Zepbound prices and providers.
Checked
Sep 25, 2026
lilly.com

If you have type 2 diabetes, check your insurance first: Part D and commercial plans can cover it for diabetes, and Lilly’s savings card can bring a covered fill down to $25. Paying cash, LillyDirect’s $499 a month is far below the $1,349 to $1,399 that some telehealth sites charge for the same pen.

Online Providers That List Mounjaro

Mounjaro is approved for type 2 diabetes. If you have diabetes, your own doctor can prescribe it, and insurance or Lilly’s $499 self-pay price will cost far less than any provider below. These three telehealth providers list Mounjaro and sell the pen themselves, at $1,349 to $1,399 a month, nearly three times Lilly’s price. A clinician decides whether it’s right for you. If your goal is weight loss, Zepbound is the same drug approved for it.

Disclosure: every provider below is an affiliate partner, and we earn a commission if you become a patient through our links. That doesn’t change the order: cards are sorted by monthly price, lowest first. How we make money.
Pallas Health logo

Pallas Health$1,349/mo flat

Checked: Sep 30, 2026

Monthly price $1,349/mo
Membership None
Insurance Cash only
$850 a month more than Lilly’s $499 self-pay price
No ratings yet
Wellorithm logo

Wellorithm$1,399/mo flat

Checked: Oct 1, 2026

Monthly price $1,399/mo
Membership None
Plan 3 months upfront
Its price note lists a dose that doesn’t exist. Confirm before you pay.
Too few ratings
Eden logo

Eden$1,399/mo

Read Review

Checked: Sep 25, 2026

Monthly price $1,399/mo
Membership (Terms) $39, then $99/mo
Insurance Not stated
FDA warning letter in June 2026; BBB rating F
Prices are for the pen and leave out lab tests, taxes and shipping unless a card says otherwise. Prices change often, so confirm the total before you pay. Stars show our editorial score for providers we’ve reviewed; other ratings come from Trustpilot.

How to Get Mounjaro for the Lowest Legal Price

Check your coverage first. Part D and commercial plans can cover it for type 2 diabetes, and Lilly’s savings card can bring a covered fill down to $25.

Paying cash? LillyDirect charges $499 a month at every dose, about a third of what some telehealth sites charge.

Use the savings card while it lasts. Lilly’s current card ends December 31, 2026.

On Medicare? Part D plans can cover it for diabetes at your plan’s copay. The $50 GLP-1 Bridge doesn’t include it.

Add a telehealth provider only if you need a prescriber, and ask where the prescription will be filled before you pay.

If your goal is weight loss, ask your clinician about Zepbound, the same drug approved for it, at $299 to $449 a month on LillyDirect.

What Is Mounjaro?

Mounjaro is Eli Lilly’s brand of tirzepatide for type 2 diabetes. The once-weekly injection acts on two gut hormone receptors, GIP and GLP-1, and helps lower blood sugar along with diet and exercise in adults and children 10 and older. It’s also approved to lower the risk of heart attack and stroke in adults with type 2 diabetes at high risk. It is not approved for weight loss.

Treatment starts at 2.5 mg a week. If blood sugar needs more control, the dose can rise in 2.5 mg steps, at least four weeks apart, up to 15 mg for adults. The most common side effects are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and stomach pain. Our GLP-1 side effects guide covers what to expect and when to call a doctor.

Zepbound contains the same drug and is the version approved for weight management: see Zepbound prices. If you’re comparing brand-name tirzepatide with a compounded version, read compounded tirzepatide prices and FDA-approved vs. compounded GLP-1s first.

Mounjaro 2.5 mg pen beside a smiling woman holding a water bottle on an outdoor walk
Common Questions

Mounjaro FAQ

$499 a month at every dose, from 2.5 to 15 mg, at LillyDirect’s self-pay price. Additional taxes and fees may apply.

No. It’s FDA-approved for type 2 diabetes in adults and children 10 and older, and to lower heart risks in adults with type 2 diabetes. Zepbound contains the same drug and is approved for weight management. Zepbound prices and providers.

Part D plans can cover it for type 2 diabetes at the plan’s usual copay. The $50 Medicare GLP-1 Bridge doesn’t include it.

Commercial plans can cover it for type 2 diabetes. If yours does, Lilly’s savings card can bring a 1-, 2- or 3-month fill down to $25, with savings up to $1,950 a year. The card ends December 31, 2026, and people with government insurance can’t use it. How GLP-1 coverage works.

Both contain tirzepatide and both come from Eli Lilly. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management and obstructive sleep apnea. Their self-pay prices differ too: Mounjaro costs $499 a month on LillyDirect, Zepbound $299 to $449.

They sell the pen themselves, close to its list price. LillyDirect sells the same pen for $499 a month with a prescription from any licensed clinician, so ask where your prescription will be filled before you pay.

No. There is no FDA-approved generic tirzepatide. Compounded tirzepatide is not FDA-approved, and the FDA has told telehealth companies not to call compounded drugs “generic.”

For type 2 diabetes, yes. The current label includes children 10 and older, with a maximum dose of 10 mg a week.

Looking More GLP-1 Medications?

How We Checked These Prices

We read LillyDirect, Lilly’s Mounjaro savings page and Medicare.gov on September 25 and 26, 2026, the FDA label on DailyMed, and each provider’s own Mounjaro pages between September 25 and October 1, 2026. We don’t buy the drug or sign up for plans. Every number comes from a published page, and each card and table row shows when we checked it. We recheck prices every month. If a price has changed, tell us.

Every provider on this page is an affiliate partner, and we earn a commission when you sign up through our links. Commissions never change the order or what we write. How we make money and our editorial policy explain the rules we follow. We drafted this page with AI assistance and checked every number against its source.

Medical Disclaimer: GLP1Rating provides information for educational purposes and does not give medical advice. GLP-1 medications require a prescription. Talk to a licensed healthcare provider before you start, stop, or change any treatment.

You May Also Like

GLP-1 + GIP
Zepbound

ZepboundFDA-approved for weight loss

GLP-1
Ozempic

OzempicFDA-approved for type 2 diabetes

Compounded GLP-1
Compounded Tirzepatide

Compounded TirzepatideCompounded, not FDA-approved

See the full catalogue of GLP-1 Medications

Keep Reading:

GLP1Rating - Independent Editorial Reviews © 2026 All Rights reserved
GLP1Rating
Logo